- Approval Id
- aff52191aa4283c1
- Drug Name
- HYDROCHLORZIDE-50 TABLET 50 mg
- Product Name
- HYDROCHLORZIDE-50 TABLET 50 mg
- Approval Number
- SIN01561P
- Approval Date
- 1988-05-27
- Registrant
- APEX PHARMA MARKETING PTE. LTD.
- Licence Holder
- APEX PHARMA MARKETING PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- TABLET
- Dosage
- **DOSAGE AND ADMINISTRATION**
To be administered orally.
ADULTS:
Oedema : Usually, 25mg to 100mg once or twice daily or intermittently to a maximum of 200mg daily.
Hypertension : 25mg to 50mg daily; either alone or in conjunction with other antihypertensive agents, to a maximum of 100mg daily.
CHILDREN
Usually 2.5mg per kg body weight a day, given in two doses.
- Route Of Administration
- ORAL
- Indication Info
- **INDICATIONS**
**Hydrochlorzide** is indicated for the treatment of oedema and hypertension.
- Contraindications
- **CONTRAINDICATIONS**
Anuria, known hypersensitivity to this product or to other sulphonamides-derived drugs.
- Atc Code
- C03AA03
- Atc Item Name
- hydrochlorothiazide
- Pharma Manufacturer Name
- APEX PHARMA MARKETING PTE. LTD.
- Company Detail Path
- /organization/apex-pharma-marketing-pte-ltd
